PSM915
TNF‑α/IL‑1β mediated autoimmune diseases
PreclinicalActive
Key Facts
Indication
TNF‑α/IL‑1β mediated autoimmune diseases
Phase
Preclinical
Status
Active
Company
About PrecisemAb Biotech
A Taiwan biotech delivering safer, tumor‑selective antibodies via a protease‑activated lock technology.
View full company profile